ucsf banner

phone    phone

The search term 'MYELOMA' revealed the following 4 open trials:

Trial Number: 09259
Phase: N/A
[View Details]

Study Title: A Prospective Observational Study of Health-Related Quality of Life, Physical Function and Respiratory Function in Patients with Myeloma Affecting the Spine: The Impact of Disease, the Incidence of Fractures and the Effect of Vertebral Augmentation with Kyphoplasty

Trial Number: 09252
Phase: Phase II
[View Details]

Study Title: An Open-label, Single-Arm, Phase 2 Study of Extended Carfilzomib Therapy in Subjects Previously Enrolled in Carfilzomib Treatment Protocols

Trial Number: 09258
Phase: Phase III
[View Details]

Study Title: A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Added to the Combination of Bortezomib and Dexamethasone in Multiple Myeloma Patients Previously Treated with Bortezomib

Trial Number: 08257
Phase: Phase III
[View Details]

Study Title: A Phase III, Randomized, Open-Label, 3-Arm Study to Determine the Efficacy and Safety of Lenalidomide (Revlimid) plus Low-Dose Dexamethasone When Given Until Progressive Disease or For 18 Four-Week Cycles Versus the Combination of Melphalan, Prednisone and Thalidomide Given for 12 Six-Week Cycles in Patients with Previously Untreated Multiple Myeloma Who are Either 65 Years of Age or Older or Not Candidates for Stem Cell Transplantation



  << back to search


Couldn't find what you were looking for? Still have questions?

Contact us


This site will look much better in a browser that supports web standards, but it is accessible to any browser or Internet device. Please upgrade your browser.